Total Company Value: Alvotech (ALVO)

Alvotech (ALVO) is optimizing expenses by outsourcing clinical trials and drug manufacturing to third-party contractors. Primary growth is driven by the expansion of biosimilars in Western countries, while the current enterprise value stands at 3112.83. The business relies on partnerships with global industry leaders to expand distribution. The share price visualized below on GURU.Markets allows for a real-time assessment of the company's market dynamics.

ALVO (alvotech.com) Total Company Value history from 11/23/2025 to 10/27/2026

Alvotech (ALVO) - metric breakdowns and financial figures

- price and consensus price forecast:

Price Chart Alvotech S.A.|ALVO - Consensus Target

- market capitalization data:

Market Value Alvotech|ALVO - Total Company Value

- book capitalization data:

Net Asset Value per Share Alvotech|ALVO - Company Book Value|Market Capitalization to Net Assets alvotech.com|ALVO - Company Total Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio Alvotech|ALVO - Long-Term Debt to Capital|Short-Term Debt to Capital alvotech.com|ALVO - Company Debts|Debt to Net Assets Ratio Alvotech

Comprehensive company analysis:Alvotech S.A. (ALVO)

An investment audit of Alvotech requires an analysis of the enterprise value, which is calculated by summing the market capitalization and debt obligations minus cash and cash equivalents. This net market price of the business reflects the actual cost of acquiring the issuer, taking into account the capital intensity of geothermal-powered biosimilar production in Iceland and the company's current debt load.

Competitor analysis for Alvotech

HLN - Total Company Value|KVUE - Real Price to Acquire Entire Company|VRNA: Total Company Value|Total Company Value MENS|LGND (ligand.com) - Total Enterprise Value|Total Company Value Amneal AMRX|Full Business Value Perrigo Company PLC|Liquidia Technologies (LQDA) - Enterprise Value|Value Adjusted for Debt and Cash Galapagos Corp (GLPG)|Enterprise Value ANIP (ANI Pharmaceuticals)|mannkindcorp.com - Enterprise Value|Total Company Value Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX: Value Adjusted for Debt and Cash|SPRY (ARS Pharma) - Total Company Value|Theravance Corp (TBPH) - Real Price to Acquire Entire Company|AQST (Aquestive Therapeutics) - Enterprise Value|Enterprise Value scPharma (SCPH)|Tectonic Therapeutic, Inc. (TECX) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash TNXP (Tonix Pharma)|SXTC: Total Company Value|EPRX - Total Enterprise Value|Real Price to Acquire Entire Company BioHarvest Sciences BHST|EXOZ - Aggregate Business Value|Enterprise Value oramed.com ORMP|Entera Bio (ENTX) - Value Adjusted for Debt and Cash|Enterprise Value HYFT (MindWalk)|Total Enterprise Value ABVC|Cumberland Pharmaceuticals (CPIX) - Total Company Value|Value Adjusted for Debt and Cash quantumbiopharma.com (QNTM)|Enterprise Value FGEN (FibroGen)|Telomir Pharmaceuticals Inc - Enterprise Value|RANI - Total Company Value|Synergy CHC Corp (SNYR) - Total Company Value|rallybio.com (RLYB) - Real Price to Acquire Entire Company|LEXX (Lexaria Bioscience Corp.) - Total Company Value|Total Company Value PULM (Pulmatrix)|Total Enterprise Value Pheton (PTHL)|Real Price to Acquire Entire Company Aptorum Group Limited|Aggregate Business Value Lyra Therapeutics Inc (LYRA)|IBO: Enterprise Value|Total Enterprise Value TNF Pharmaceuticals Inc. TNFA|YCBD: Enterprise Value|PRFX - Real Price to Acquire Entire Company|Enterprise Value altamiratherapeutics.com CYTO|Lipella Pharma (LIPO) - Value Adjusted for Debt and Cash|OPTN (OptiNose, Inc.) - Enterprise Value|Enterprise Value PIRS|Total Company Value Procaps (PROC)|Total Company Value Petros Pharmaceuticals Inc PTPI|Real Price to Acquire Entire Company Qilian International Holding Group Limited QLI|ACELYRIN Inc. - Total Company Value|TFFP (TFF Pharmaceuticals) - Total Company Value